Article Versions Notes

Oshi M, Asaoka M, Tokumaru Y, Angarita FA, Yan L, Matsuyama R, Zsiros E, Ishikawa T, Endo I, Takabe K. Abundance of Regulatory T Cell (Treg) as a Predictive Biomarker for Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer. Cancers. 2020; 12(10):3038. https://doi.org/10.3390/cancers12103038

Oshi, Masanori, Mariko Asaoka, Yoshihisa Tokumaru, Fernando A. Angarita, Li Yan, Ryusei Matsuyama, Emese Zsiros, Takashi Ishikawa, Itaru Endo, and Kazuaki Takabe. 2020. "Abundance of Regulatory T Cell (Treg) as a Predictive Biomarker for Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer" Cancers 12, no. 10: 3038. https://doi.org/10.3390/cancers12103038

Oshi, M., Asaoka, M., Tokumaru, Y., Angarita, F. A., Yan, L., Matsuyama, R., Zsiros, E., Ishikawa, T., Endo, I., & Takabe, K. (2020). Abundance of Regulatory T Cell (Treg) as a Predictive Biomarker for Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer. Cancers, 12(10), 3038. https://doi.org/10.3390/cancers12103038